Recently, it was shown that BCR-ABL1-expressing and imatinib-resistant cell lines and their CML counterparts displayed a higher level of the PARP1 and DNA ligase IIIα proteins crucial for DNA double strand breaks repair in these cells [19]. Here, PARP1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.